PUBLISHED DECISION GUIDE
COVID-19 Diagnosis and Treatment Protocol (Trial Version 7)
An overview of the official Chinese national guideline for COVID-19 management, issued by the National Health Commission.
The National Health Commission of China issued the Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7) on March 3, 2020, to guide clinical management amidst the evolving pandemic. [citation:3a299e3b-2a9b-4278-9552-95603d33020b]
Independently written English guidance based on cited public sources. Every public guide is human reviewed; it is not an official translation of the source publisher.
Background and Purpose
The protocol was developed based on increased clinical observations and pathology of COVID-19, as well as accumulated experience in diagnosis and treatment. [citation:3a299e3b-2a9b-4278-9552-95603d33020b]
It acknowledges the global situation at the time: outbreak contained domestically to a certain extent but rising overseas. [citation:3a299e3b-2a9b-4278-9552-95603d33020b]
Key Updates in Trial Version 7
Compared to the previous version, the protocol includes updates concerning transmission routes, case definitions, discharge criteria, and therapeutic measures. [citation:3a299e3b-2a9b-4278-9552-95603d33020b]
Public sources
Editorial process
Editorial review and corrections
This guide received human editorial review. Use its public sources and review date to assess the current information boundary.
Request an editorial correction